Showing of 11 results
Breaking Into the Brain: Overcoming Barriers to Understand Autism and Brain Tumors
Matthew Anderson, MD, PhD, and Tyler Miller, MD, PhD, discuss how immune biology is reshaping neuroscience - from autism and obesity to CAR T cell therapies for glioblastoma and the challenge of crossing the blood brain barrier.
A Regional Powerhouse for Cancer Discovery and Patient Impact
Theodoros Teknos, MD, and Gary Schwartz, MD, discuss how a $25.5 million NCI grant renewal reinforces Case Comprehensive Cancer Center’s leadership in clinical trials, early detection, and cancer prevention across Northeast Ohio.
De-Escalation, Genomics and Multidisciplinary Care Redefines Breast Cancer Treatment
Amanda Amin, MD, Janice Lyons, MD and Alberto Montero, MD, explore the evolution of breast cancer treatment. The discussion highlights how personalized care, clinical innovation and compassionate teamwork are transforming patient outcomes.
Uncovering the Mycobiome: Fungi, Gut Health, and Disease
Mahmoud Ghannoum, PhD shares his work on the role of fungi in the microbiome and groundbreaking research on the mycobiome’s impact on health, including its role in gut disorders, autism, and cancer.
Unlocking Prostate Cancer Screening and Genetic Insights on Aging
Jonathan Shoag, MD, discusses his innovative prostate cancer research aiming to better understand the impact of PSA screening and his groundbreaking work on the genetics of aging.
Navigating the Complex Mechanisms of HPV+ Head and Neck Cancers
Quintin Pan, PhD, explores the surge of HPV+ related head and neck cancers sparking the need for innovative treatment solutions.
EsoCheck™ & EsoGuard™: Revolutionary Invention Transforms Esophageal Cancer Diagnostics
Amitabh Chak, MD, Sanford Markowitz, MD, PhD, and Joseph Willis, MD, explain the journey of EsoCheck™ and EsoGuard™, an incredible bench to bedside diagnostic discovery to detect Barrett's esophagus and prevent esophageal cancer.
From Bench to Bedside: Non-Small Cell Lung Cancer Discovery Creates Hope
Afshin Dowlati, MD describes how his team of researchers discovered a new non-small cell lung cancer subtype in the laboratory and brought a new treatment for this cancer subtype to patients in a clinical trial.